Indication

Mixed hyperlipidemia

Mixed hyperlipidemia is a metabolic disorder of lipid clearance and overproduction that primarily impacts the vascular and cardiovascular systems. Read more about Mixed hyperlipidemia

284 drugs 119 manufacturers

Advertisement

Drugs that treat it

Common Mixed hyperlipidemia therapies.

Showing 46–54 of 284 drugs

FLUVASTATIN SODIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+5
TEVA USA

ATORVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
DR.REDDY'S LAB

ATORVASTATIN CALCIUM

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+11
GREENSTONE LLC.

NIACIN

HYPERCHOLESTEROLEMIA·+6
SUNMARK

SIMVASTATIN

ANTIHYPERLIPIDEMICS HMGCO-A REDUCTASE INHIBITORS (STATINS)·HYPERCHOLESTEROLEMIA·+13
GEN-SOURCE RX
Filter & compare in the drug finder →Opens the drug finder with Mixed hyperlipidemia preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Mixed hyperlipidemia.

Mixed hyperlipidemia is a metabolic disorder of lipid clearance and overproduction that primarily impacts the vascular and cardiovascular systems.

It is defined by the concurrent elevation of both serum cholesterol, primarily carried on low-density lipoprotein (LDL), and triglycerides, typically enriched in very-low-density lipoproteins (VLDL) and remnant lipoproteins.

This atherogenic profile frequently presents with decreased high-density lipoprotein cholesterol (HDL-C) and an increased concentration of apolipoprotein B-containing particles.

It can arise as a primary genetic condition, such as familial combined hyperlipidemia, or secondary to metabolic derangements including obesity, insulin resistance, type 2 diabetes mellitus, and nephrotic syndrome.

Personalize your experience

Follow Mixed hyperlipidemia and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it